These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9033470)

  • 1. Interferon for hepatitis C.
    Puoti C; Magrini A; Stati T; Rossi P; Montagnese F; Resta S
    Lancet; 1997 Feb; 349(9049):398-9. PubMed ID: 9033470
    [No Abstract]   [Full Text] [Related]  

  • 2. Recovery from chronic hepatitis C in long-term responders to ribavirin plus interferon alfa.
    Fontaine H; Chaix ML; Lagneau JL; Bréchot C; Pol S
    Lancet; 2000 Jul; 356(9223):41. PubMed ID: 10892765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pegylated interferon alpha-2b in patients with acute hepatitis C.
    Mukhopadhyay A
    Natl Med J India; 2006; 19(4):201-2. PubMed ID: 17100108
    [No Abstract]   [Full Text] [Related]  

  • 4. Managing patients with hepatitis C.
    Drug Ther Bull; 1993 Aug; 31(16):61-2. PubMed ID: 8375275
    [No Abstract]   [Full Text] [Related]  

  • 5. Towards more individualised management of hepatitis C virus patients with initially or persistently normal alanineaminotransferase levels.
    Alberti A
    J Hepatol; 2005 Feb; 42(2):266-74. PubMed ID: 15664254
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of the primary care physician in the diagnosis and management of hepatitis C virus infection.
    Spach DH
    J Am Board Fam Pract; 1999; 12(6):497-500. PubMed ID: 10612371
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acute hepatitis C: response to treatment with interferon-alpha plus ribavirin].
    Vega Palomares R; Planas Vilà R; Durández Lazaro R; Fábregas Puigtió S
    Gastroenterol Hepatol; 2002 Oct; 25(8):483-6. PubMed ID: 12361528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant alpha-interferon in renal allograft recipients with chronic hepatitis C.
    Ozgür O; Boyacioğlu S; Telatar H; Haberal M
    Nephrol Dial Transplant; 1995 Nov; 10(11):2104-6. PubMed ID: 8643176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parameters predicting response to alpha-interferon treatment in chronic hepatitis C.
    Glück T; Seelig R; Dette S; Bühring HJ; Renz M; Kwon S; Wiedmann KH; Weber P
    Hepatogastroenterology; 1997; 44(14):484-91. PubMed ID: 9164523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic response to alpha-interferon in chronic alcoholics with viral hepatitis C].
    Nikitin IG; Kuznetsov SL; Liuliaeva OD; Storozhakov GI; Kisliakov VA; Uskov IuI
    Klin Med (Mosk); 1998; 76(8):33-5. PubMed ID: 9770965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained virological response following extremely short antiviral treatment in selected HCV carriers with persistently normal ALT.
    Puoti C; Guarisco R; Spilabotti L; Bellis L
    Dig Liver Dis; 2010 Oct; 42(10):745. PubMed ID: 20303840
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.
    Weiland O; Chen M; Lindh G; Mattsson L; Schvarcz R; Sönnerborg A; Wahl M; Wejstål R; Widell A; Norkrans G
    Scand J Infect Dis; 1995; 27(4):319-24. PubMed ID: 8658063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is it now the time to update treatment protocols for lymphomas with new anti-virus systems?
    Luppi M; Barozzi P; Potenza L; Riva G; Morselli M; Torelli G
    Leukemia; 2004 Oct; 18(10):1572-5. PubMed ID: 15284857
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hepatitis C virus genotype 4: epidemiology and treatment].
    Castera L; Morice Y; Grando V; Bon C; Dény P; Roulot D
    Gastroenterol Clin Biol; 2003 Jun; 27(6-7):596-604. PubMed ID: 12910223
    [No Abstract]   [Full Text] [Related]  

  • 15. Virological and biochemical responses to interferon-alpha in chronic hepatitis C.
    Pawlotsky JM; Roudot-Thoraval F; Duvoux C; Dhumeaux D; Babany G; Duval J
    Lancet; 1994 Jan; 343(8888):54. PubMed ID: 7905063
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatic hepatitis C virus RNA in chronic hepatitis C.
    Craxì A; Di Marco V; Almasio PL
    Ann Intern Med; 1996 Jan; 124(1 Pt 1):72. PubMed ID: 7503483
    [No Abstract]   [Full Text] [Related]  

  • 17. Association between type II cryoglobulinemia and hepatitis C virus in a case treated with interferon-alpha.
    Fukumoto S; Ishimura E; Shoji S; Izumotani T; Kitahashi S; Kuroki T; Nishizawa Y; Morii H
    Nephron; 1996; 73(1):94-6. PubMed ID: 8742965
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatitis C: infection and current treatment strategies.
    Piascik P
    J Am Pharm Assoc (Wash); 1997; NS37(4):376-8. PubMed ID: 9519644
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of low-dose intermittent interferon-alpha monotherapy in patients infected with hepatitis C virus genotype 1b who were predicted or failed to respond to pegylated interferon plus ribavirin combination therapy.
    Akuta N; Suzuki F; Kawamura Y; Yatsuji H; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Arase Y; Ikeda K; Kumada H
    J Med Virol; 2008 Aug; 80(8):1363-9. PubMed ID: 18551610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
    Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
    Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.